Clinical trial Recruiting at 1 site Interventional Ages 20 to 60

Evaluating PRP injections for knee osteoarthritis treatment

Official title: Therapeutic Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis and Periarticular Tissue Injury

Run by Xijing Hospital · NCT06082531 · Data updated 2026-11-12

This study is testing whether platelet-rich plasma (PRP) injections can help people with knee osteoarthritis and related injuries feel better.

Quick facts

Study typeInterventional
Ages20 Years to 60 Years
SexAll
Enrollment300 (estimated)
SponsorXijing Hospital
Academic / other
Drugs / interventionscart, chemotherapy
Locations1 site (Xi'an, Shannxi)
StatusRecruiting
StartedSeptember 1, 2023
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJuly 30, 2026
Trial IDNCT06082531 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 20 to 60 with diagnosed knee osteoarthritis or meniscus injuries.

Probably not a fit

Patients with significant abnormalities in platelet count or function, systemic infections, or those undergoing certain treatments like chemotherapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to assess the safety and effectiveness of platelet-rich plasma (PRP) injection therapy for patients suffering from knee osteoarthritis and related soft tissue injuries. Conducted at a single center, the study will involve participants aged 20 to 60 who have been diagnosed with knee osteoarthritis or meniscus injuries. The methodology includes administering PRP injections and monitoring the outcomes to establish a reliable treatment approach for joint injuries.

Why it matters

Potential benefit: If successful, this treatment could provide a new, effective option for patients with knee osteoarthritis, potentially improving their quality of life.

How similar studies have gone: Other studies have shown promising results with PRP injections for joint injuries, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The age range of the participants was 20 to 60 years old. Through a comprehensive clinical and imaging examination, it was conclusively determined that the individuals had knee osteoarthritis or experienced injuries to the cart, and meniscus surrounding the knee joint.
* The preoperative routine tests and examinations revealed no contraindications.
* Revised sentence: "Informed consent of the patient

Exclusion Criteria:

* The platelet count or function exhibits significant abnormalities、Systemic infection transmitted through the bloodstream.
* Prolonged usage of anti-inflammatory drugs and systemic corticoid administration.
* In injection site or damage to the skin.
* Patients with tumors or undergoing radiotherapy and chemotherapy.
* Pregnant or breastfeeding women.
* Individuals with mental illnesses who are unable to cooperate with follow-up procedures.
* Contraindications for MRI、Patients or their families do consent to participate in the study.
* Other circumstances that render participation in the study unsuitable.

Where it's running

  • Xijing Hospital
    Xi'an, Shannxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.